Dennis Slamon and Sujuan Ba
Mar 27, 2025, 13:34
Dennis Slamon and Sujuan Ba on HER2 Cancers – NFCR
National Foundation for Cancer Research (NFCR) shared a post on LinkedIn:
“In Episode 3 of All Things Cancer, we are joined by Dr. Dennis Slamon, a pivotal figure in the successful development of Herceptin for treating HER2-positive breast cancer.
Tune in as Dr. Slamon discusses his revolutionary work, breakthrough therapies, and the future of cancer treatment. This is a conversation you won’t want to miss!
Listen now.
Discover the ground breaking podcast, All Things Cancer, brought to you by NFCR!
Join us as we team up with industry leaders to share powerful insights from the heroes battling cancer on the frontlines. Also available on Youtube, Apple Podcasts and more!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 20, 2025, 14:56
Apr 20, 2025, 14:07
Apr 20, 2025, 13:49
Apr 20, 2025, 13:31